MGEN - シグナル・ジェネティクス (Miragen Therapeutics Inc.) シグナル・ジェネティクス

 MGENのチャート


 MGENの企業情報

symbol MGEN
会社名 Miragen Therapeutics Inc (シグナル・ジェネティクス)
分野(sector) Health Care   ヘルスケア
産業(industry) Medical Specialities  
業種 バイオテクノロジ―_メディカルリサ―チ   医療関連(Health Care)
概要 事業概要 ミラジェン・セラピューティクス(Miragen Therapeutics Inc.)(旧名: Signal Genetics Inc.)は臨床病期のバイオ医薬品会社である。同社はマイクロRNAに焦点を置いて、満たされていない医療ニーズが高い病気に役立つリボ核酸(RNA)標的治療薬の発見・開発に従事する。特定の癌治療用臨床製品候補MRG-106は、いくつかの血液癌で異常に高レベルに見られるマイクロRNA-155(miR-155)の阻害剤である。病理学的線維症の治療用臨床製品候補MRG-201は、心臓、腎臓、肝臓、肺線維症及び全身性硬化症を含む多様な病理学的線維症状態において異常に低いレベルで見出されるmiR-29の代替物である。臨床プログラムに加えて、前臨床製品候補のパイプラインの発見・開発を行う。同社の前臨床製品候補はMRG-107とMRG-110を含む。  シグナル・ジェネティクスは米国のバイオテクノロジ―メ―カ―。がん患者のケアおよび治療に焦点を充てた診断製品の開発とサ―ビスに注力する。主な製品には多発性骨髄腫のリスクが高い患者を特定する遺伝子シグネチャ―検査「MyPRS (Myeloma Prognostic Risk Signature)」がある。   
本社所在地 6200 Lookout Road Boulder CO 80301 USA
代表者氏名 William Stuart Marshall ウィリアム・スチュアート・マーシャル
代表者役職名 President Chief Executive Officer Director 社長兼最高経営責任者(CEO)
電話番号 +1 303-531-5952
設立年月日 40179
市場名 NASDAQ Small Cap
ipoyear 2014年
従業員数 65人
url www.miragentherapeutics.com
nasdaq_url https://www.nasdaq.com/symbol/mgen
adr_tso
EBITDA EBITDA(百万ドル) -25.42500
終値(lastsale) 5.26
時価総額(marketcap) 159606073.6
時価総額 時価総額(百万ドル) 145.33670
売上高 売上高(百万ドル) 9.78900
企業価値(EV) 企業価値(EV)(百万ドル) 79.18570
当期純利益 当期純利益(百万ドル) -25.59500
決算概要 決算概要 BRIEF: For the six months ended 30 June 2018 Miragen Therapeutics Inc revenues increased from $1.2M to $7M. Net loss applicable to common stockholders decreased 6% to $13.4M. Revenues reflect Collaboration revenue increase from $498K to $6.1M Grant revenue increase of 23% to $842K. Lower net loss reflects General and administrative decrease of 14% to $4.5M (expense) Interest and other income increase from $132K to $528K (income).

 MGENのテクニカル分析


 MGENのニュース

   Miragen Therapeutics Inc. Shares Close the Week 22.6% Higher - Weekly Wrap  2021/01/15 22:30:00 Kwhen Finance
Miragen Therapeutics Inc. shares closed this week 22.6% higher than it did at the end of last week. The stock is currently up 40.0% year-to-date, up 126.6% over the past 12 months, and up 136.2% over the past five years. This week, the Dow Jones Industrial Average fell 0.9%, and the S&P 500 fell 1.5%. Trading Activity Shares traded as high as $25.67 and as low as $19.45 this week.Shares closed 2e+1% below its 52-week high and 3e+2% above its 52-week low.Trading volume this week was 22.7% lower than the 10-day average and 44.0% higher than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.4. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought.The stock closed at 0.6% higher than its 5-day moving average, 20.2% higher than its 20-day moving average, and 51.5% higher than its 90-day moving average. Market Comparative Performance The company's share price beats the S&P 500 Index this week, beats it on a 1-year basis, and beats it on a 5-year basis The company's share price beats the Dow Jones Industrial Average this week, beats it on a 1-year basis, and beats it on a 5-year basis The company share price beats the performance of its peers in the Health Care industry sector this week, beats it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's stock priceperformance year-to-date beats the peer average by 8.0% The company's stock price performance over the past 12 months beats the peer average by 8.5% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
   Miragen Therapeutics Inc. Shares Close the Day 16.7% Higher - Daily Wrap  2021/01/11 22:30:00 Kwhen Finance
Miragen Therapeutics Inc. shares closed today 16.7% higher than it did at the end of yesterday. The stock is currently up 14.2% year-to-date, up 74.0% over the past 12 months, and up 78.7% over the past five years. Today, the Dow Jones Industrial Average fell 0.3%, and the S&P 500 fell 0.7%. Trading Activity Shares traded as high as $23.90 and as low as $16.39 this week.Shares closed 3e+1% below its 52-week high and 3e+2% above its 52-week low.Trading volume this week was 202.6% higher than the 10-day average and 332.3% higher than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.4. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price beats the S&P 500 Index today, beats it on a 1-year basis, and lags it on a 5-year basis The company's share price beats the Dow Jones Industrial Average today, beats it on a 1-year basis, and lags it on a 5-year basis The company share price beats the performance of its peers in the Health Care industry sector today, beats it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock priceperformance year-to-date lags the peer average by -49.7% The company's stock price performance over the past 12 months lags the peer average by -38.5% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
   Miragen Therapeutics Inc. Shares Close the Week 17.3% Higher - Weekly Wrap  2020/12/11 22:30:00 Kwhen Finance
Miragen Therapeutics Inc. shares closed the week 17.3% higher than it did at the end of last week. The stock is currently up 170.5% year-to-date, up 103.2% over the past 12 months, and up 68.6% over the past five years. This week, the Dow Jones Industrial Average rose 0.2%, and the S&P 500 rose 0.0%. Trading Activity Shares traded as high as $19.95 and as low as $16.36 this week. Trading volume this week was 4.1% lower than the 10-day average and 45.1% lower than the 30-day average. Beta, a measure of the stocks volatility relative to the overall market stands at 0.4. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought. MACD, a trend-following momentum indicator, indicates an upward trend. The stock closed below its Bollinger band, indicating it may be oversold. The stock closed at Infinity% higher than its 5-day moving average, 12.6% higher than its 20-day moving average, and 36.5% higher than its 90-day moving average. Market Comparative Performance The company's share price beats the S&P 500 Index this week, beats it on a 1-year basis, and lags it on a 5-year basis The company's share price beats the Dow Jones Industrial Average this week, beats it on a 1-year basis, and lags it on a 5-year basis The company share price beats the performance of its peers in the Health Care industry sector this week, beats it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's price-earnings ratio is the same as its average peer. The company's performance over the last 1 year beats its average peer by 7.1% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
   61 Biggest Movers From Yesterday - Stocks News Feed  2020/11/18 10:08:23 Stocks News Feed
Gainers Riot Blockchain, Inc. (NASDAQ: RIOT) shares jumped 48.4% to close at $6.09 on Tuesday amid strength in Bitcoin prices. Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) shares jumped 40.3% to close at $1.81 on Tuesday as the company disclosed that both the SOLOIST and SCORED Phase 3 studies achieved their primary endpoints. Miragen Therapeutics, Inc. (NASDAQ:… Read More »61 Biggest Movers From Yesterday
   MiRagen reports loss, effects reverse stock split  2020/11/12 23:23:28 Broomfield Enterprise
MiRagen Therapeutics Inc. (Nasdaq: MGEN), a Boulder-based biotechnology company developing new treatments for patients with diseases that are underserved by current therapies, reported a net loss o…
   Value-Added Acquisition Clears the Runway for Miragen Therapeutics  2020/11/09 16:58:07 InvestorPlace
It was thrilling to watch MGEN stock spike, and the bull move might not be over as Miragen's new acquisition puts high-need medicine in focus.
   Nasdaq again threatens to delist MiRagen over sub-$1 stock price  2020/10/15 23:55:36 Hometown Weekly
The Nasdaq has again warned MiRagen Therapeutics Inc. (Nasdaq: MGEN) that it could be removed from the market if its stock remains under $1 per share through next April.
   AMD, SWIR among premarket gainers  2020/07/24 12:24:43 Seeking Alpha
Natuzzi NTZ +131% on renewing its securitization facility. Miragen Therapeutics MGEN +45% on Orphan Drug tag for Cobomarsen in blood cancer. Theratechnolog
   61 Biggest Movers From Yesterday - Stocks News Feed  2020/11/18 10:08:23 Stocks News Feed
Gainers Riot Blockchain, Inc. (NASDAQ: RIOT) shares jumped 48.4% to close at $6.09 on Tuesday amid strength in Bitcoin prices. Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) shares jumped 40.3% to close at $1.81 on Tuesday as the company disclosed that both the SOLOIST and SCORED Phase 3 studies achieved their primary endpoints. Miragen Therapeutics, Inc. (NASDAQ:… Read More »61 Biggest Movers From Yesterday
   MiRagen reports loss, effects reverse stock split  2020/11/12 23:23:28 Broomfield Enterprise
MiRagen Therapeutics Inc. (Nasdaq: MGEN), a Boulder-based biotechnology company developing new treatments for patients with diseases that are underserved by current therapies, reported a net loss o…
   Value-Added Acquisition Clears the Runway for Miragen Therapeutics  2020/11/09 16:58:07 InvestorPlace
It was thrilling to watch MGEN stock spike, and the bull move might not be over as Miragen's new acquisition puts high-need medicine in focus.
   Nasdaq again threatens to delist MiRagen over sub-$1 stock price  2020/10/15 23:55:36 Hometown Weekly
The Nasdaq has again warned MiRagen Therapeutics Inc. (Nasdaq: MGEN) that it could be removed from the market if its stock remains under $1 per share through next April.
   AMD, SWIR among premarket gainers  2020/07/24 12:24:43 Seeking Alpha
Natuzzi NTZ +131% on renewing its securitization facility. Miragen Therapeutics MGEN +45% on Orphan Drug tag for Cobomarsen in blood cancer. Theratechnolog

 関連キーワード  (バイオテクノロジ―_メディカルリサ―チ 米国株 シグナル・ジェネティクス MGEN Miragen Therapeutics Inc.)

 twitter  (公式ツイッターやCEOツイッターなど)